[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
García Pérez
A
A
Valverde de La Osa
J
J
Giménez Samper
M
M
Alonso García
I
I
D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000209:etiology*; D001729:Bismuth / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D005756:Gastritis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D016481:Helicobacter Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D016480:Helicobacter pylori; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008795:Metronidazole / Q000627:therapeutic use*; D009853:Omeprazole / Q000627:therapeutic use*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000209:etiology*; D012459:Salicylates / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use*
D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D012459:Salicylates; D008795:Metronidazole; C015715:bismuth subsalicylate; D000658:Amoxicillin; D007770:L-Lactate Dehydrogenase; D013752:Tetracycline; D009853:Omeprazole; D001729:Bismuth